TiGenix opens US headquarters
Operations to be based in Cambridge at heart of Boston area biotech hub
30-Jun-2017 -
TiGenix NV announces it has opened an U.S. office in Cambridge, Massachusetts. Establishing U.S. operations is a significant step for TiGenix and will support its strategic goal of developing and commercializing its lead product, Cx601, for the treatment of complex perianal fistulas in Crohn's ...
biopharmaceuticals
biotechnology
Crohn's disease